To evaluate the influence of calcium entry blockade (diltiazem 60 mg qid) on exercise capacity in patients with chronic atrial fibrillation, nine men (mean age 65 years) with atrial fibrillation underwent maximal treadmill exercise on and off diltiazem therapy. Heart rate, blood pressure, and measured ventilatory parameters were assessed at a standard submaximal workload (3.0 mph/0% grade), the gas exchange anaerobic threshold (ATge), and maximal exercise. Significant reductions in heart rate at all stages of exercise were demonstrated: maximum heart rate deprevious therapeutic interventions in patients with chronic atrial fibrillation have been either ineffective in controlling the ventricular response during exercise, ie, digitalis,'-3 or are associated with a reduced aerobic capacity, ie, beta blockade.48 Since electrophysiologic studies have shown calcium entry blockers to be efficacious in depressing A-V nodal conduction (negative dromotropic effect) thereby controlling the ventricular rate,912 they have been recom-
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following calcium entry blockade. The present study was therefore initiated to evaluate the effect of moderate dose diltiazem on hemodynamic and respiratory gas exchange variables in patients with chronic atrial fibrillation. patient were receiving digitalis therapy. None of the patients was in congestive heart failure at the time of the study, and all were New
METHODS
York Heart Association functional class 1 or 2. All patients had left atrial enlargement with normal left ventricular function as interpreted by M-mode and 2-D echocardiography prior to entering the study. Routine pulmonary function tests demonstrated normal pulmonary function for all patients. Patients were administered diltiazem, 60 mg orally four times per day for at least seven days prior to exercise testing. One patient was unable to tolerate this dose due to light-headedness and was reduced to 30 mg four times daily. Each test was performed two to four hours after taking the last diltiazem dose.
Testing Procedures
Patients were exercised on a calibrated motor-driven treadmill and instructed to abstain from food, coffee, and cigarettes for at least three hours prior to testing. From two previous maximal treadmill tests with gas exchange analysis, individualized protocols were designed for each patient such that the maximal exercise test lasted between 10 to 12 minutes. These protocols conformed to guidelines for optimizing cardiopulmonary assessment as outlined by Buchfuhrer et al.28 The patients subjective perception of exertion was evaluated using the Borg 6 to 20 point scale.29 All exercise tests were continued to volitional fatigue or dyspnea or both, and no patient was limited by angina.
Pulmonary gas exchange variables were determined continuously throughout the exercise test using an exercise testing system (Beckman Horizon MMC). The precision of this system has been validated by Jones.30 The reproducibility of the exercise system employed in the present study was documented using techniques outlined by Jones and Campbell.3'
A standard 12-lead ECG and blood pressure were obtained at rest, throughout the exercise test, and recovery period. The number of ECG complexes multiplied by a factor of ten in a six second rhythm strip at the end of each minute was used to determine heart rate. Blood pressure was determined using a clinical sphygmomanometer at rest during the last minute of each stage of exercise, at maximum effort, and during recovery.
Points of Analysis
Analysis of hemodynamic and pulmonary gas exchange variables were performed at a submaximal workload (3.0 mph/0% grade), the gas exchange anaerobic threshold (ATge), and maximal exertion. Pulmonary gas exchange variables include oxygen uptake (Vo2, ml/kg-min STPD), carbon dioxide production (Vco2, L/min STPD), minute ventilation (VE, L/min BTPS), oxygen pulse (oxygen uptake ml/min divided by heart rate), and respiratory exchange ratio (RER=-Vco2 divided by Vo2). The ATge was determined by two independent blinded observers as outlined by Sullivan et al. 32 All results were entered into a Lotus 1 2 3 spreadsheet, analyzed by paired Student's t-test (Minitab), and presented as means and standard deviations.
RESULTS
Heart rate, blood pressure, and pulmonary gas exchange variables observed at rest, submaximal exercise (3.0 mph/0% grade), gas exchange anaerobic threshold (ATge), and maximal exertion are presented in Tables 2 and 3 .
Resting Data
As shown in Table 2 , standing heart rate was significantly reduced during administration of diltiazem. However, there was no statistically significant difference in resting systolic or diastolic blood pressure on and off diltiazem therapy. Progressive Exercise Figure 1 demonstrates that heart rate remained significantly reduced throughout exercise during diltiazem therapy, while systolic and diastolic blood pressure were unchanged. Figure 2 plots minute ventilation versus oxygen uptake, and illustrates that diltiazem had no influence on these gas exchange variables.
Submaximal Exercise (3.0 mphl0% grade) A significant mean decrease of 27 beats/min (22 percent) occurred at 3.0 mph/0% grade during diltiazem therapy (Table 2 ). There were no statistically significant differences between the two treatments in any of the gas exchange variables at this point of analysis except for an increase in oxygen pulse due to the significant decrease in heart rate. Of primary note is that although hemodynamic variables were reduced and oxygen pulse rose during diltiazem therapy, there was no change in oxygen uptake or perceived level of exertion at this moderate workload.
Gas Exchange Anaerobic Threshold (ATge) and Maximum Exertion
There was a mean decrease in heart rate of 29 Figure 3 demonstrates no significant change in mean maximal oxygen uptake, and Figure 4 demonstrates no change in treadmill time during diltiazem versus control therapy.
DISCUSSION
Since Mackenzie33 noted a remarkable response to digitalis in patients with congestive heart failure and "auricular fibrillation," digitalis and its derivatives have been the primary form of therapy for this arrhythmia. Digitalis, through its negative dromotropic effect causing reduced conduction of atrial stimuli, improved the patient's hemodynamic and symptomatic state. However, digoxin has been relatively ineffective in controlling the resting heart rate in some atrial fibrillation patients during acute illness and in most during Diltiazem exercise. Goldman and coworkers3 reporte( rate control with digoxin in only seven of 1( unstable chronic atrial fibrillation patients; a of digoxin was required to control the response in 15 of 43 instances. Several exercise studies using digoxin ar fibrillation patients have shown an inordin heart rate response during the initial pha Mean cise, [34] [35] [36] perhaps due to loss of vagotonic effect, or improved A-V node conduction due to increased catecholamines. With the advent of newer pharmacologic agents such as beta-adrenergic and calcium entry blockers which prolong the refractory period of the A-V node, other methods for controlling the rapid exercise heart rate in patients with atrial fibrillation have been entertained. Studies utilizing beta-adrenergic blockade, although demonstrating heart rate control, have had inconsistent effects on exercise performance. 343 The calcium entry blockers, diltiazem and verapamil, have been utilized to control resting heart rate in patients with atrial fibrillation. The 25 percent reduction in resting heart rate after diltiazem in the present study is consistent with several reports using verapamil,'4'l7 and two using diltiazem9," in patients with chronic atrial fibrillation. Though beta blockade, when used for patients with atrial fibrillation, has limited maximal heart rate to roughly 120 beats/min,34 37 and among subjects in normal sinus rhythm, has elevated perceived exertion at the same oxygen uptake.4042 The higher maximum heart rate afforded by diltiazem (141 beats/min) may have preserved functional capacity since heart rate is the major mechanism for increasing cardiac output beyond 60 percent of maximal capacity. Since diltiazem controlled the ventricular response without compromising gas exchange variables or perceived exertion, it has important clnical and practical implications for patients with chronic atrial fibrillation.
On the other hand, ifa reduction in myocardial oxygen demand (ie, rate-pressure product) is the major goal of therapy, then beta-adrenergic blockade may provide better results, albeit at the expense of functional capacity. In conclusion, diltiazem exerts a significant negative dromotropic effect in patients with chronic atrial fibrillation thereby controlling heart rate. It accomplishes this without compromising aerobic capacity, and hence, is an effective agent in supplement to digoxin therapy for treatment of chronic atrial fibrillation.
